Assessing the Quality of Life of Patients With Rosacea
1 other identifier
interventional
160
1 country
1
Brief Summary
The study population consisted of 160 patients (123 women and 37 men) with rosacea, who agreed to participate in this study. Patients were qualified for the study among people visiting the cosmetic studio in Choroszcz in the period from June 2017 to November 2018, based on the diagnosis of a dermatologist and cosmetologist. The cosmetic intervention was performed using CAPILLARY REPAIR SERUM (30ml). Study participants completed self-reported questionnaire and standardized questionnaires.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 8, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2018
CompletedFirst Submitted
Initial submission to the registry
February 6, 2024
CompletedFirst Posted
Study publicly available on registry
February 21, 2024
CompletedFebruary 21, 2024
February 1, 2024
1.6 years
February 6, 2024
February 14, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Elements influenced on quality of life of participants with rosacea
The aim of the study was to assess whether antioxidant cosmetic procedures and selected lifestyle elements, especially dietary antioxidants have a significant impact on the quality of life of patients with rosacea.
17 months
Secondary Outcomes (6)
Self-reported questionnaire
17 months
Dietary Questionnaire
17 months
The Physical Activity Questionnaire
17 months
DLQI (Dermatology Life Quality Index)
17 months
SWLS (Satisfaction With Life Scale)
17 months
- +1 more secondary outcomes
Study Arms (1)
Participants with rosacea
EXPERIMENTALInterventions
Cosmetic procedures were performed on a group of patients after a cosmetic interview containing questions about contraindications to the procedure. The treatment was performed 3-times at 2-week intervals and consisted of cavitation peeling and sonophore-sis with an antioxidant preparation dedicated to vascular skin. The F-808 Skin Scrubber device was used for the treatment. After a month, the procedure was repeated. The stages of a cosmetologist's procedure during a cosmetic intervention were as follows: 1. make-up removal; 2. skin diagnostics, exclusion of contraindications, discussion of the procedure; 3. cavitation peeling - gentle skin cleansing using ultrasound; 4. applying an antioxidant cosmetic mixture (composition: rutin, horse chestnut and arnica extract, acerola, vitamin C, moisturizing complex of algae); 5. performing sonophoresis treatment; 6. applying the cream at the end; 7. discussion of indications for further care.
Eligibility Criteria
You may qualify if:
- diagnosis of rosacea according to the criteria of the National Rosacea Society Expert Committee (NRSEC) from 2019,
- tolerance to the ingredients of the preparation used in the cosmetic intervention,
- lack of pregnancy and lactation,
- completion of a survey,
- signed informed consent
You may not qualify if:
- age \< 30 years,
- patients with other facial skin diseases (e.g. acne, psoriasis, eczema),
- intolerance to the ingredients of the preparation used in the cosmetic treatment,
- patients with neuropsychiatric diseases, pregnancy, lactation,
- patients who did not sign informed consent to participate in the study
- did not complete the survey questionnaire.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medical University of Bialystoklead
- University of Lomzacollaborator
Study Sites (1)
Medical University of Bialystok
Bialystok, 15-089, Poland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Małgorzata E Zujko, Dr.
Medical Univeristy of Bialystok
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 6, 2024
First Posted
February 21, 2024
Study Start
May 8, 2017
Primary Completion
November 30, 2018
Study Completion
November 30, 2018
Last Updated
February 21, 2024
Record last verified: 2024-02